International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 652-653 , 1 March 2008

Technology Assessment: Vigilance Required

  • W. Robert Lee, M.D., M.S., M. Ed.

      Affiliations

    • Corresponding Author InformationReprint requests to: W. Robert Lee, M.D., M.S., M.Ed., Department of Radiation Oncology, DUMC 3085, Durham, NC 27710. Tel: (919) 668-7342; Fax: (919) 668-7345

Received 17 September 2007 ,Accepted 26 September 2007.

References 

  1. Borger C, Smith S, Truffer C, et al. Health spending projections through 2015: Changes on the horizon. Health Aff (Millwood). 2006;25:w61–w73
  2. Emanuel EJ, Fuchs VR, Garber AM. Essential elements of a technology and outcomes assessment initiative. JAMA. 2007;298:1323–1325
  3. D'Ambrosio DJ, Pollack A, Harris EER, et al. Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70:671–677
  4. Postman N. Amusing ourselves to death: Public discourse in the age of show business. New York: Penguin; 1985;
  5. Postman N. Technopoly: The surrender of culture to technology. New York: Vintage Books; 1992;
  6. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial. Lancet. 1999;353:267–272
  7. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006;66:981–991
  8. Zelefsky MJ, Moughan J, Owen J, et al. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Int J Radiat Oncol Biol Phys. 2004;59:1053–1061
  9. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2005;352:1977–1984
  10. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7

 Conflict of interest: none.

PII: S0360-3016(07)04257-5

doi: 10.1016/j.ijrobp.2007.09.030

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 652-653 , 1 March 2008

Article Tools